BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 19617333)

  • 1. Single-shot cardiorenal scintigraphy with 99mTc-tetrofosmin: a dynamic characterization at rest and during adenosine infusion.
    Fommei E; Bruselli L; Ripoli A; Gimelli A; Ghione S; Giorgetti A; Kush A; Tagliavia ID; Passino C; Marzullo P
    J Nucl Med; 2009 Aug; 50(8):1288-95. PubMed ID: 19617333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of microsphere-equivalent blood flow (15O-water PET) and relative perfusion (99mTc-tetrofosmin SPECT) in myocardium showing metabolism-perfusion mismatch.
    Schaefer WM; Nowak B; Kaiser HJ; Koch KC; Block S; vom Dahl J; Buell U
    J Nucl Med; 2003 Jan; 44(1):33-9. PubMed ID: 12515874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cardiac to hepatic uptake of 99mTc-tetrofosmin with and without adenosine infusion to predict the presence of haemodynamically significant coronary artery disease.
    Squires SR; Bushnell DL; Menda Y; Graham MM
    Nucl Med Commun; 2005 Jun; 26(6):513-8. PubMed ID: 15891594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting the response to cardiac resynchronization therapy using 99mTc-tetrofosmin myocardial scintigraphy in patients with drug-refractory heart failure: additional value of the washout of 99mTc-tetrofosmin.
    Shigeru M; Fujiwara S; Takamine S; Yoshida A; Kawai H; Shiotani H; Hirata K
    Nucl Med Commun; 2014 Sep; 35(9):939-46. PubMed ID: 24977350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of nitroglycerin on myocardial 99mTc-Tetrofosmin uptake defects in coronary artery disease.
    Tarkowska A; Cholewiński W; Widomska-Czekajska T; Stefaniak B; Poniatowicz-Frasunek E; Wypych M; Chrapko B
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):254-68. PubMed ID: 12898848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early post-stress pulmonary uptake of 99mTc tetrofosmin during exercise (SPECT) myocardial perfusion imaging: correlation with haemodynamic, perfusion and function parameters.
    Georgoulias P; Demakopoulos N; Kontos A; Xaplanteris P; Xydis K; Fezoylidis I
    Nucl Med Commun; 2006 Feb; 27(2):119-26. PubMed ID: 16404224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of transient left ventricular dilatation on rest and exercise on Tc-99m tetrofosmin myocardial SPECT.
    Kinoshita N; Sugihara H; Adachi Y; Nakamura T; Azuma A; Kohno Y; Nakagawa M
    Clin Nucl Med; 2002 Jan; 27(1):34-9. PubMed ID: 11805482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceleration of hepatobiliary excretion by lemon juice on 99mTc-tetrofosmin cardiac SPECT.
    Cherng SC; Chen YH; Lee MS; Yang SP; Huang WS; Cheng CY
    Nucl Med Commun; 2006 Nov; 27(11):859-64. PubMed ID: 17021425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and image quality of dual-isotope SPECT using 18F-FDG and (99m)Tc-tetrofosmin after acipimox administration.
    Kam BL; Valkema R; Poldermans D; Bax JJ; Reijs AE; Rambaldi R; Boersma E; Rietveld T; Roelandt JR; Krenning EP
    J Nucl Med; 2003 Feb; 44(2):140-5. PubMed ID: 12571201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline/postnitrate tetrofosmin SPECT for myocardial viability assessment in patients with postischemic severe left ventricular dysfunction: new evidence from MRI.
    Giorgetti A; Pingitore A; Favilli B; Kusch A; Lombardi M; Marzullo P
    J Nucl Med; 2005 Aug; 46(8):1285-93. PubMed ID: 16085584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of absolute myocardial blood flow in humans using dynamic cardiac SPECT and
    Shrestha U; Sciammarella M; Alhassen F; Yeghiazarians Y; Ellin J; Verdin E; Boyle A; Seo Y; Botvinick EH; Gullberg GT
    J Nucl Cardiol; 2017 Feb; 24(1):268-277. PubMed ID: 26715603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficiency comparison between 99m Tc-tetrofosmin and 99m Tc-sestamibi myocardial perfusion studies.
    Ravizzini GC; Hanson MW; Shaw LK; Wong TZ; Hagge RJ; Pagnanelli RA; Jain D; Lima HS; Coleman RE; Borges-Neto S
    Nucl Med Commun; 2002 Mar; 23(3):203-8. PubMed ID: 11891477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 99mTc tetrofosmin myocardial perfusion scintigraphy in CAD. Performance with early and standard delayed acquisition and fractional flow reserve.
    Pirich C; Keinrath P; Rettenbacher L; Rendl G; Holzmannhofer J; Hammerer M; Schuler J; Beheshti M
    Nuklearmedizin; 2014; 53(3):111-6. PubMed ID: 24963973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Simultaneous assessment of myocardial perfusion and ventricular function using thallium-201 at rest/Tc-99m tetrofosmin at effort with single-photon emission computerized tomography, synchronized with electrocardiogram (synchronized SPECT). Initial experience in Latin America].
    Puente A; Alexánderson E; Arroyo A; Lorenzo A; Victoria D
    Arch Inst Cardiol Mex; 2000; 70(5):448-55. PubMed ID: 11534095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial viability assessment with gated SPECT Tc-99m tetrofosmin % wall thickening: comparison with F-18 FDG-PET.
    Maruyama A; Hasegawa S; Paul AK; Xiuli M; Yoshioka J; Maruyama K; Hori M; Nishimura T
    Ann Nucl Med; 2002 Feb; 16(1):25-32. PubMed ID: 11922205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of renal function by calculation of fractional uptake of technetium-99m dimercaptosuccinic acid.
    Beatović SLj; Jaksić ED; Han RS
    Nucl Med Rev Cent East Eur; 2004; 7(1):49-52. PubMed ID: 15318311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome prediction in patients at high risk for coronary artery disease: comparison between 99mTc tetrofosmin and 99mTc sestamibi.
    Borges-Neto S; Tuttle RH; Shaw LK; Smith WT; Jain D; Coleman RE; Whellan D
    Radiology; 2004 Jul; 232(1):58-65. PubMed ID: 15220493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats.
    Hatada K; Riou LM; Ruiz M; Yamamichi Y; Duatti A; Lima RL; Goode AR; Watson DD; Beller GA; Glover DK
    J Nucl Med; 2004 Dec; 45(12):2095-101. PubMed ID: 15585487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of absolute Tc-99m tetrofosmin retention in the myocardium as an index of myocardial blood flow and coronary flow reserve by gated-SPECT/CT: a feasibility study.
    Apostolopoulos DJ; Kaspiri A; Spyridonidis T; Patsouras N; Savvopoulos CA; Davlouros P; Vassilakos PJ; Alexopoulos D
    Ann Nucl Med; 2015 Aug; 29(7):588-602. PubMed ID: 25971450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of technetium-99m N,N-ethylenedicysteine renal scintigraphy in the evaluation of differential renal function and cortical defects.
    Buyukdereli G; Guney IB
    Clin Nucl Med; 2006 Mar; 31(3):134-8. PubMed ID: 16495730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.